Breast Cancer, Version 3.2013
Richard L. Theriault(Memorial Sloan Kettering Cancer Center), Rashmi Kumar(University of London), Robert W. Carlson(National Comprehensive Cancer Network), Stephen B. Edge(American Society of Clinical Oncology), Richard C. Zellars(The University of Texas at San Antonio Health Science Center), George Somlo(City Of Hope National Medical Center), Antonio C. Wolff(Johns Hopkins University), Sharon H. Giordano(The University of Texas MD Anderson Cancer Center), Mary Lou Smith(Research Advocacy Network), Beryl McCormick(Memorial Sloan Kettering Cancer Center), Lori J. Pierce(University of Michigan–Ann Arbor), Andres Forero(University of Alabama at Birmingham), Clifford A. Hudis(American Society of Clinical Oncology), Lori J. Goldstein(Shaanxi Research Association for Women and Family), Harold J. Burstein(Dana-Farber Cancer Institute), Benjamin O. Anderson(University of Washington), Elizabeth Reed(Cancer Institute (WIA)), Ingrid A. Mayer(Vanderbilt University), Daniel F. Hayes(University of Michigan–Ann Arbor), David A. Mankoff(University of Pennsylvania), Lee S. Schwartzberg(Renown Health), Dorothy A. Shead(University of the Witwatersrand), William J. Gradishar(Northwestern University), Hatem Soliman(Moffitt Cancer Center), John H. Ward(Unknown), Craig Allred(Nottingham City Hospital), Britt‐Marie E. Ljung, Steven J. Isakoff(Harvard University), William B. Farrar, P. Kelly Marcom(Duke University)
Cited by 193
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.2k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k